Full course description

About this course

Precision Medicine for Your Practice is a series of short (20-30 min), online modules covering specific topics in genomics and precision medicine. In this module, Genomic Testing for the Healthy Individual, learn how to elicit patient motivations for genomic testing and to assess if a particular genomic test is a good fit for their concerns. This module will help providers understand the benefits and limitations of different types of genomic tests, know what types of information are available from different types of tests, and increase provider awareness of resources available to help interpret and prioritize results from genomic testing. There are five parts of the module: overview via an animated video; practice cases to facilitate learning-by-doing; "dig deeper" for more in-depth topics; and logistics and additional resources for more detail.

Already enrolled? Access the course here.


Release Date: January 19, 2018
Expiration Date: July 20, 2018

Upon completion of this educational activity, the learner will be able to:

  • Identify patient motivators to enable decisions regarding genomic testing. 
  • Facilitate interpretation of genomic test results from a wide range of test types, including those with lower clinical validity and utility.

Target Audience
This activity is designed to meet the educational needs of practicing nurses and/or advanced practice nurses, physicians and physician assistants.

CNE Approval Statement
The Jackson Laboratory is co-providing this continuing nursing education activity with the American Medical Association and Scripps Translational Science Institute. This continuing nursing education activity was approved by the Northeast Multi-State Division (NE-MSD), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Claiming Your Credit
In order to claim credit 1) answer the pre-assessment questions, 2) work through the module content in its entirety, 3) successfully complete the post-assessment answering 2 out of 3 questions correctly and 4) complete the evaluation.    

Nurses are eligible for a maximum of .50 contact hours upon the completion of this activity.

Planning Committee

  • Barry D. Dickinson, PhD, CME Program Committee, AMA
  • Abdallah Elias, MD, Department of Medical Genetics, Shodair Children's Hospital
  • Jeanette McCarthy, MPH, PhD, Visiting Associate Professor, Division of Medical Genetics, UCSF School of Medicine
  • Laura Nicholson, MD, Co-Director of Education, Scripps Translational Science Institute
  • James O'Leary, MBA, Chief innovation Officer, Genetic Alliance
  • Janet K. Williams, PhD, RN, FAAN, Professor of Nursing, Chair of Behavioral and Social Science Research, University of Iowa


  • Barry D. Dickinson, PhD, CME Program Committee, AMA (Content Reviewer)
  • Emily Edelman, MS, CGC, Associate Director, Clinical and Continuing Education, The Jackson Laboratory (Author)
  • Therese Ingram Nissen, MA, Senior Instructional Designer/Technologist, The Jackson Laboratory (Author)
  • Laura Nicholson, MD, Co-Director of Education, Scripps Translational Science Institute (Author)
  • Kate Reed, MPH, ScM, CGC, Director, Clinical and Continuing Education, The Jackson Laboratory (Author)
  • Linda Steinmark, MS, CGC, Project Director, Clinical and Continuing Education, The Jackson Laboratory (Author)
  • Janet K. Williams, PhD, RN, FAAN, Professor of Nursing, Chair of Behavioral and Social Science Research, University of Iowa (Content Reviewer)

Conflict of Interest Disclosure
Unless otherwise noted, the program planners and faculty do not have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this course.

The following disclosures are reported that could be perceived as a real or apparent conflict of interest in the education program:

Jeanette McCarthy, PhD, MPH, consultant to Omica, Inc. and past paid presenter for Illumina, Inc., stockholder of Omica, Inc.

Janet K. Williams, PhD, RN, FAAN, stockholder of Pfizer

In their roles as planners, Dr. McCarthy and Dr. Williams recused themselves from all deliberations relating to content related to the commercial entities with which they have a financial interest and will not be responsible for reviewing for bias the presentation of any faculty who share the same financial interests. All educational material has been peer-reviewed by external reviewers to assess for bias.

No other planners or faculty have relevant financial relationships to disclose.


American College of Medical Genetics and Genomics. Clinical utility of genetic and genomic services: a position statement. Genet Med. 2015; 17(6):505-507.

American College of Medical Genetics and Genomics. Direct-to-consumer genetic testing: a revised position statement. Genet Med. 2015; 18(2):207-208.

American College of Medical Genetics and Genomics. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement. Genet Med. 2016; 19(2):249-255.

Baptista NM, Christensen KD, Carere DA, Broadley SA, Roberts JS, Green RC. Adopting genetics: motivations and outcomes of personal genomic testing in adult adoptees. Genet Med. 2016; 18(9):924-932.

Bunnik EM, Janssens ACJW, Schermer MHN. Personal utility in genomic testing: is there such a thing? J Med Ethics. 2015; 41(4):322-326.

Garrison NA, Non AL. Direct-to-Consumer Genomics Companies Should Provide Guidance to Their Customers on (Not) Sharing Personal Genomic Information. The American Journal of Bioethics. 2014; 14(11):55-57.

Kirkpatrick BE, Rashkin MD. Ancestry Testing and the Practice of Genetic Counseling. J Genet Counsel. 2016; 26(1):6-20.

Kozlovskaia M, Vlahovich N, Ashton KJ, Hughes DC. Biomedical Risk Factors of Achilles Tendinopathy in Physically Active People: a Systematic Review. Sports Med - Open. 2017; 3(1):20-33.

Linderman M, Nielsen D, Green R. Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq Consortium. 2016; 6(2):14-29.

Lindor NM, Thibodeau SN, Burke W. Whole-Genome Sequencing in Healthy People. Mayo Clinic Proceedings. 2017; 92(1):159-172.

Lu M, Lewis CM, Traylor M. Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe. BMC Med Genomics. 2017; 10(1):47-54.

Lupo PJ, Robinson JO, Diamond PM et al. Patients’ perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project. Personalized Medicine. 2016; 13(1):13-20.

Niemiec E, Howard HC. Ethical issues in consumer genome sequencing: Use of consumers' samples and data. Applied & Translational Genomics. 2016; 8:23-30.

Ostergren JE, Gornick MC, Carere DA et al. How Well Do Customers of Direct-to-Consumer Personal Genomic Testing Services Comprehend Genetic Test Results? Findings from the Impact of Personal Genomics Study. Public Health Genomics. 2015; 18(4):216-224.

Topol E. Individualized Medicine from Pre-womb to Tomb. 2014; 157(1):241-253.

Vassy JL, Christensen KD, Schonman EF et al. The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients. Ann Intern Med. 2017; 167(3):159-70.

Wang L, McLeod HL, Weinshilboum RM. Genomics and Drug Response. N Engl J Med. 2011; 364(12):1144-1153.

Wasson K, Sanders TN, Hogan NS, Cherny S, Helzlsouer KJ. Primary care patients’ views and decisions about, experience of and reactions to direct-to-consumer genetic testing: a longitudinal study. J Community Genet. 2013; 4(4):495-505.


Hardware/software Requirements

Audio speakers or headphones
Screen resolution of 800X600 or higher
Adobe Reader 5.0 or higher 

As of June 4, 2016, we support the following versions of Flash and popular web browsers:

Operating Systems

  • Windows 7 and newer
  • Mac OSX 10.6 and newer
  • Linux - chromeOS

Mobile Operating System Native App Support

  • iOS 7 and newer
  • Android 4.2 and newer

Should you have questions regarding the content of the activity or if you need technical support, please email Clinical and Continuing Education at the Jackson Laboratory.